Aktuella utlysningar, vecka 11, 2022
Grants Office tipsar om aktuella utlysningar.
Svenska och nordiska utlysningar
AIDA Innovation projects - Medtech4Health
Aim to develop and adopt artificial intelligence-based decision support methods for imaging diagnostics. Grants may cover up to 50 percent of costs for project proposals of between SEK 500,000 and SEK 1 million.
Closing date: 19 April 2022
AIDA clinical evaluation funding - Medtech4Health
Supports clinical evaluation of commercially available artificial intelligence solutions in healthcare relevant for diagnostic imaging operations. Grants may cover up to 50 percent of costs for proposals of between SEK 100,000 and SEK 300,000.
Closing date: 19 April 2022
Annual open call for research projects - Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)
Enables researchers to formulate their own research questions based based on societal challenges within the council’s areas of responsibility. Funding is worth up to SEK 3 million for one, two or three years.
Closing date: 21 April 2022
Annual open call for research projects for early-career researchers - Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)
Supports research and development projects in the field of environment, agricultural sciences and spatial planning by early-career researchers. Grants are worth SEK 1 million per year for up to four years.
Closing date: 21 April 2022
Research on kidney transplants - Stiftelsen Professor Lars-Erik Gelins Minnesfond
Provides grants for scientific research projects, focusing on kidney transplantation but also other areas of uremic care. The foundation's statutes regulate the requirements for projects to be granted funding. The projects shall be conducted at institutions in Sweden. The Foundation may also award scholarships, for staff in the field of transplantation wanting to develop their competence.
Closing date: 30 April 2022
Information for those that applied to The Einhorn family Foundation
The Einhorn Family Foundation awards grants for projects aiming to promote health and wellbeing, primarily for children, in low- and middle-income countries. Most successful applications are based on a scientific project.
Due to an unfortunate error in the e-mail system any application addressed to email@example.com before Mars 14 may be lost in cyberspace. So please, if you applied to the foundation before the 14 of Mars, send it again, preferably with a copy to firstname.lastname@example.org. If the application was sent to email@example.com or you have received a mail acknowledging receipt of your application it need not be resent. We apologize for any inconvenience.
Swiss Bridge award -- Swiss Cancer League | Krebsliga Schweiz, CH and other funders
This supports cancer research in Europe. The focus topic for this year is cancer and infection.
Young investigators from academic and cancer research institutions in Europe are eligible to apply.
The total budget is CHF 500,000 and grants are worth up to CHF 250,000 each.
Closing date: 30 April 2022
Public engagement grants -- Society for Endocrinology, GB
These support the organisation and delivery of outreach activities, aimed at school children or the general public, that engage audiences with hormones and the impact of endocrinology.
Full and early-career members may apply.
Closing date: 23 March 2022 (additional deadlines 21 September 2022)
Fellow’s award -- MQ: Transforming Mental Health, GB
This supports early-career scientists who are asking challenging questions that will contribute to transformative advances in mental health research as they establish their independence. In the 2022 call the focus of the projects should be on premature death. Research can be based in the laboratory, clinic or field and may involve theoretical, experimental, social science or medical humanities approaches to the remit.
Researchers anywhere in the world from all disciplines related to mental health research may apply. Applicants must be early-career researchers.
Funding is worth up to £225,000 for up to three years.
Closing date: 29 April 2022
Young investigator programme -- European Molecular Biology Organisation, EUR
This supports junior group leaders in the field of life sciences to set up their first independent laboratories. Applications are accepted from candidates who:
•have been an independent group leader for at least one year at the pre-application deadline and less than four years on 1 January in the year of application;
•work in the life sciences in a European Molecular Biology Conference member state, associate member state or co-operating partner country;
•have obtained sufficient funding to run their laboratory;
•have published at least one last author research paper in an international peer reviewed journal;
Awards are worth €15,000 each paid to investigators in their second year. Investigators may also apply for small grants of up to €10,000 per year.
Closing date: 1 April 2022
Deadline Information Preliminary applications due by 1 April 2022; full applications due by 14 July 2022. This call is repeated once a year.
New venture fellowship -- European Molecular Biology Organisation, EUR
This supports early-career scientists in exploring topics outside their current area to allow them to pursue a new research direction in their future work. Projects must have a biological significance and should increase knowledge on a particular biological process.
Applicants must be active researchers in any field of life science research with a minimum of two years’ research experience at the PhD level, and no more than two years’ experience as an independent group leader. Fellowships include funding for travel costs and subsistence of the fellow for up to three months.
Closing date: 2 May 2022
Juniors bridge grants -- European Society for Immunodeficiencies, EUR
These support trainees working on primary immunodeficiencies in continuing their activity at their institution or another institution during short periods of time until they can find other financial sources. Applicants must be junior members of the society.
Grants are worth up to €1,500 each per month for up to six months.
Closing date: 24 April 2022
RESPIRE4: Marie Skłodowska-Curie COFUND scheme Postdoctoral Research Fellowships
The European Respiratory Society’s (ERS) RESPIRE4 (REspiratory Science Promoted by International Research Exchanges 4) fellowship programme (RESPIRE)
The RESPIRE fellowship programme is open to researchers with a PhD or four years of full-time research experience from any discipline. Fellowship recipients have the flexibility to choose and develop their own research project, but research must be related to the respiratory field.
Closing date: 1 May, 2022
Fellows can apply for Postdoc Opportunity
Principal Investigators can register as Host Centre to be included in the RESPIRE4 Web Host Registry to host fellows.
Federal Funding agencies
Innovation for HIV vaccine discovery (R01 clinical trial not allowed), NIH: National Institute of Allergy and Infectious Diseases
The purpose of this Funding Opportunity Announcement (FOA) is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high risk, high impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated “Go/No-Go” criteria by the end of Year 2.
Closing date: July 28, 2022. All applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-20-158
Advancing Genomic Medicine Research (R01, R21 Clinical Trial Optional), NIH
This Funding Opportunity Announcement (FOA) encourages applications that stimulate innovation and advance understanding of when, where, and how best to implement the use of genomic information and technologies in clinical care. Proposed projects should be broadly applicable to genomic medicine as a field, and yield findings of significance beyond a single disease, gene, or setting. Projects are strongly encouraged to include ancestrally diverse and underrepresented participants and populations.
Closing date: August 1, 2022; March 13, 2023. All applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-HG-20-036 (R01), RFA-HG-20-037 (R21)
Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed), NIH
This Funding Opportunity Announcement (FOA) encourages exploratory and developmental research to better understand the role of social connectedness and/or loneliness in prevention, treatment and recovery from substance use disorders (SUDs). Research may use a variety of approaches, including leveraging existing data sources, survey research, social network analysis, new methods development, feasibility research, etc. Outcomes of interest include any of the following: substance use initiation, escalation, SUD diagnosis, connection to treatment, and engagement or retention in treatment or recovery.
Closing date: August 15, 2022. All applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-DA-23-009
Patient-partnered collaborations for single-cell analysis of rare inflammatory paediatric disease, Chan Zuckerberg Initiative, US
The Chan Zuckerberg Initiative invites applications from collaborative teams bringing together patient-led rare disease organizations and research teams for 4-year research projects aimed at advancing our understanding of the fundamental science of rare diseases. The Patient-Partnered Collaborations for Single-Cell Analysis of Rare Inflammatory Pediatric Disease RFA aims to support the application of single-cell biology methods to rare inflammatory pediatric diseases that will clarify cellular mechanisms of disease, understand disease heterogeneity, and improve biomarker identification or diagnostics.
Awards are $2,000,000 USD total costs for four years for each project (distributed amongst research institutions and a patient organization). The award period for each RFA is an initial two years of funding, followed by an additional two years, pending evaluation.
Closing date: May 24, 2022. Applications due by 5 p.m. Pacific Time.
Research grants, Progeria Research Foundation, US
The Progeria Research Foundation awards grants to applicants who seek to conduct research to find the cause, treatment, or cure for Hutchinson-Gilford Progeria Syndrome (Progeria, or HGPS). Research Focus: PRF’s research focus is highly translational. Topics must fall within the following research priorities:
- Projects that are likely to lead to clinical treatment trials within 5 years. This includes the discovery and/or testing of candidate treatment compounds in cell-based or animal models of HGPS. Only proposals that test compounds in a progerin-producing animal or cell model will normally be considered. Analyses in non progerin-producing models are acceptable, but only as a comparison to progerin-producing models and with strong justification.
- Development of gene-, biomolecule-, drug-, and cell-based therapies to treat Progeria
- Assessment of natural history of disease that may be important to developing outcome measures in treatment trials (preclinical or clinical)
Eligibility: Principal Investigators must hold faculty appointments or equivalent at institutions with 501(c)(3) taxexempt status, or the equivalent for foreign institutions. Co-Principal Investigators are allowed. Proposed projects must have specific relevance to HGPS and show promise for contributing to the scientific or clinical advancement in this field of study (see Research Focus in item II).
Budget: Awards are typically for 1-2 years at a maximum of $75,000/year. investigators may be invited to submit a follow-up Phase II grant proposal. These Phase II Grant proposals are generally by invitation only. No INDI coverage!
Closing date: July 1, 2022 (Letter of Intent) by 5:00 PM EST. October 3, 2022, Full application due by 5:00 PM EST.